Treatments
Autism Spectrum Disorder
Autism Spectrum Disorder — Investigational cell and extracellular-vesicle protocols have been proposed for autism, but proposed immune or neural mechanisms do not establish improvement in core autistic features.
Open →Diabetes (Type 1 & 2)
Diabetes (Type 1 & 2) — MSC protocols aim to modulate the autoimmune attack in type-1 diabetes and improve insulin sensitivity and beta-cell environment in type-2, as an adjunct to medical management.
Open →Multiple Sclerosis
Multiple Sclerosis — Regenerative protocols pair immunomodulation to calm autoimmune demyelination with neurotrophic support, used alongside disease-modifying therapy.
Open →Parkinson's Disease
Parkinson's Disease — Neural-lineage and MSC protocols aim to support dopaminergic pathways and reduce neuro-inflammation, complementing levodopa-based care.
Open →Alzheimer's Disease
Alzheimer's Disease — MSC and exosome protocols target neuro-inflammation and synaptic support in early-stage cognitive decline, as an adjunct to standard care.
Open →Cerebral Palsy
Cerebral Palsy — MSC protocols aim to reduce neuro-inflammation and support motor pathways in children with CP, paired with physiotherapy.
Open →Spinal Muscular Atrophy
Spinal Muscular Atrophy — Adjunctive regenerative protocols aim to support motor-neuron environment and muscle function alongside approved gene and SMN-targeted therapies.
Open →Muscular Dystrophy
Muscular Dystrophy — Protocols aim to modulate inflammation and support the muscle-repair environment in dystrophic muscle, as supportive care.
Open →Rheumatoid Arthritis
Rheumatoid Arthritis — Immunomodulatory MSC protocols aim to dampen the autoimmune inflammation driving joint damage, as an adjunct to DMARDs.
Open →Liver Cirrhosis
Liver Cirrhosis — MSC protocols aim to reduce hepatic inflammation and fibrosis and support residual liver function in compensated disease.
Open →Anemia
Anemia — Selected anaemias linked to marrow or immune dysfunction are addressed with supportive cell protocols within a haematology framework.
Open →Arterial Hypertension
Arterial Hypertension — Regenerative protocols target endothelial function and vascular inflammation as an adjunct to antihypertensive medication.
Open →Erectile Dysfunction
Erectile Dysfunction — MSC and exosome protocols aim to regenerate penile vascular and erectile tissue, targeting the underlying vascular cause rather than symptoms.
Open →Male Infertility
Male Infertility — Protocols explore regenerative support of testicular function in selected non-obstructive cases, within a fertility-specialist framework.
Open →Primary Immunodeficiency
Primary Immunodeficiency — Haematopoietic stem-cell transplantation is established for selected primary immunodeficiencies; this must not be conflated with commercial MSC, fetal-cell or extracellular-vesicle products.
Open →Aesthetic & Anti-Ageing
Aesthetic & Anti-Ageing — Exosome, fibroblast and placenta-derived products are marketed in aesthetics, but product-specific evidence, safety and regulatory status must be verified.
Open →Intellectual Disability
Intellectual Disability — Investigational protocols aim to support neurodevelopment via neural-lineage and MSC cells, paired with developmental therapy.
Open →Knee Osteoarthritis
Knee Osteoarthritis — Intra-articular MSC and chondrocyte protocols aim to reduce joint inflammation and support cartilage in osteoarthritic knees — a regenerative alternative or bridge to replacement surgery.
Open →Back Pain & Disc Degeneration
Back Pain & Disc Degeneration — Targeted MSC protocols aim to calm inflammation in degenerative discs and facet joints, addressing chronic mechanical back pain without spinal fusion.
Open →Peripheral Neuropathy
Peripheral Neuropathy — MSC and neurogenic protocols target the nerve-supporting environment and microvascular damage behind diabetic and idiopathic neuropathy.
Open →Stroke Recovery
Stroke Recovery — In the recovery phase after stroke, regenerative protocols aim to support neuroplasticity and reduce residual neuro-inflammation alongside rehabilitation.
Open →COPD & Lung Disease
COPD & Lung Disease — Intravenous and nebulised MSC/exosome protocols aim to reduce airway inflammation and support lung tissue in COPD, as an adjunct to standard respiratory care.
Open →Crohn's & IBD
Crohn's & IBD — Immunomodulatory MSC protocols target the autoimmune inflammation driving Crohn's disease and inflammatory bowel disease, as an adjunct to biologics.
Open →Lupus (SLE)
Lupus (SLE) — MSC protocols aim to re-balance the overactive immune response in systemic lupus, as an adjunct to immunosuppressive therapy.
Open →Chronic Kidney Disease
Chronic Kidney Disease — MSC protocols aim to reduce renal inflammation and fibrosis and support residual kidney function in earlier-stage CKD.
Open →Hair Loss & Restoration
Hair Loss & Restoration — Exosome and fibroblast scalp protocols aim to revitalise hair follicles and the scalp microenvironment for androgenetic and diffuse hair loss.
Open →Long COVID
Long COVID — MSC and exosome protocols target the persistent inflammation and immune dysregulation behind long-COVID fatigue and brain-fog, as supportive care.
Open →Spinal Cord Injury
Spinal Cord Injury — Neural-lineage and MSC protocols aim to support the injured-cord micro-environment, reduce secondary inflammation and encourage neuroplasticity, used alongside intensive rehabilitation.
Open →Heart Failure & Cardiac Repair
Heart Failure & Cardiac Repair — MSC and exosome protocols aim to reduce cardiac inflammation and fibrosis and support the microvasculature after heart damage, as an adjunct to standard cardiology care.
Open →ALS (Motor Neurone Disease)
ALS (Motor Neurone Disease) — Protocols explore neurotrophic and immunomodulatory support of the motor-neuron environment in ALS, as supportive care alongside approved therapies.
Open →Psoriasis
Psoriasis — Immunomodulatory MSC and exosome protocols aim to calm the autoimmune inflammation driving psoriatic skin and joint disease, as an adjunct to dermatological care.
Open →Osteoporosis & Bone Health
Osteoporosis & Bone Health — MSC protocols explore support of the bone-forming environment and reduction of bone-resorbing inflammation in osteoporosis, as an adjunct to standard treatment.
Open →Tendon & Sports Injuries
Tendon & Sports Injuries — Localised MSC and extracellular-vesicle approaches are studied for tendon, ligament and cartilage injuries; evidence depends on the exact product, comparator and outcome.
Open →Chronic Wounds & Ulcers
Chronic Wounds & Ulcers — Cell and extracellular-vesicle approaches are studied in chronic wounds, including diabetic-foot and pressure ulcers; they should not replace established wound and vascular care.
Open →Macular Degeneration & Vision
Macular Degeneration & Vision — Cell-based protocols, including iPS-cell-derived retinal approaches, aim to support the retina in age-related macular degeneration and selected retinal disease.
Open →Fibromyalgia & Chronic Fatigue
Fibromyalgia & Chronic Fatigue — MSC and exosome protocols target the chronic inflammation and immune dysregulation linked to fibromyalgia and chronic-fatigue symptoms, as supportive care.
Open →Hip Osteoarthritis
Hip Osteoarthritis — Intra-articular MSC and chondrocyte protocols aim to reduce hip-joint inflammation and support cartilage — a regenerative option or bridge to hip replacement.
Open →Scleroderma (Systemic Sclerosis)
Scleroderma (Systemic Sclerosis) — Autologous HSCT may be considered in specialist centres for carefully selected severe systemic sclerosis; commercial MSC products are a different, investigational category.
Open →Premature Ovarian Insufficiency
Premature Ovarian Insufficiency — MSC protocols explore support of the ovarian environment in premature ovarian insufficiency and diminished reserve, within a fertility-specialist framework.
Open →Menopause & Hormonal Health
Menopause & Hormonal Health — Cell, extracellular-vesicle and placenta-derived products are marketed for menopause-related wellness, but they are not established substitutes for evidence-based menopause care.
Open →Complex Regional Pain Syndrome
Complex Regional Pain Syndrome — MSC and neural-lineage products have been proposed for CRPS, but mechanistic hypotheses and case reports do not establish pain or functional benefit.
Open →Ulcerative Colitis
Ulcerative Colitis — Immunomodulatory MSC protocols target the autoimmune inflammation driving ulcerative colitis, as an adjunct to biologics and standard IBD care.
Open →